6 at 600 nm. Synthesis of the recombinant protein
was then initiated by adding isopropyl-β-D-thiogalactopyranoside (IPTG) (Sigma-Aldrich, St. Louis, MO) to a final concentration of 1 mM to the growing culture and the bacterial extract was pelleted and resuspended in phosphate buffered saline (1 × PBS). After Pitavastatin mouse induction, the cells were incubated for 2 h at 37°C with shaking at 200 rpm. Cells were harvested by centrifugation at 10,000 × g for 5 min at 4°C. The supernatant was discarded and the cells were resuspended in 1 × PBS buffer. E coli cells were incubated for 60 min with lysozyme (100 μg/mL). After addition of 1% v/v Sarcosyl at 4°C, the cells were lysed by extensive sonication. The sample was centrifuged 8,000 × g for 15 min at 4°C and 2% v/v Triton was added to the supernatant containing the soluble protein fraction. His-tagged PbMLSr was purified using the Ni-NTA Spin Kit (Qiagen Ruboxistaurin molecular weight Inc., Germantown, MD) and the tags were subsequently removed by the addition of EKMax™ Enterokinase (GIBCO™, Invitrogen, MRT67307 in vitro Carlsbad, CA). Antibody production The purified PbMLSr was used to produce anti-PbMLSr polyclonal antibodies in New Zealand rabbits. The immunization protocol consisted of an initial injection of 300 μg of purified recombinant
protein in complete Freund’s adjuvant and two subsequent injections of the same amount of the antigen in incomplete Freund’s adjuvant. Each immunization was followed by an interval of 14 days. After the fourth immunization, the serum containing the anti-PbMLSr polyclonal
antibody was collected and stored at -20°C. Western blotting analysis SDS-PAGE was performed in 12% polyacrylamide gels according to Laemmli Exoribonuclease [49]. The proteins were electrophoresed and stained with Coomassie brilliant blue or transferred to a nylon membrane and checked with Ponceau S to determine equal loading. PbMLS, as well as PbMLSr, were detected with the polyclonal antibody raised against the recombinant protein (diluted 1: 4000). After reaction with alkaline phosphatase anti-mouse immunoglobulin G (IgG) or alkaline phosphatase anti-human IgG, the reaction was developed with 5-bromo-4-chloro-3-indolylphosphate-nitroblue tetrazolium (BCIP-NBT). Cell wall protein extractions Yeast cells were frozen in liquid nitrogen and disrupted using a mortar and pestle. The procedure was carried out until complete cell rupture, verified by microscopic analysis, and by the failure of cells to grow on Fava Netto’s medium. Ground material was lyophilized and resuspended in 25 μL Tris buffer (50 mM Tris-HCl, pH 7.8) for each milligram of dry weight, as previously described [50]. The supernatant was separated from the cell wall fraction by centrifugation at 10,000 × g for 10 min at 4°C. The crude extract was kept and a new protein extraction was performed with the Tris buffer as described above.